申请人:Merck Frosst Canada, Inc.
公开号:US05605906A1
公开(公告)日:1997-02-25
Disclosed are novel cannabinoid (CB2) receptor agonists, their compositions, and the methods of their preparation. The compounds are useful for lowering ocular intra ocular pressure, treating glaucoma, useful as antiinflammatory, immunosuppressive, analgesics agents, and as agents for treatment and prevention of emesis and nausea because of the activity on the cannabinoid receptor.
本发明涉及一种新型大麻素(CB2)受体激动剂、其组合物以及其制备方法。该化合物可用于降低眼内压,治疗青光眼,作为抗炎、免疫抑制、镇痛剂和治疗和预防呕吐和恶心的药物,因为其对大麻素受体的活性。